Weekly Supply Chain in Asia 2026-W26 (2026-06-18~2026-06-24)
This archive may reflect later corrections or updates from the stored Markdown source. Already published Substack issues are not edited from this site.
Memory chip costs have reportedly risen fourfold since last year, and Apple CEO Tim Cook has warned that surging memory and storage chip costs are becoming “unsustainable.” Elsewhere, Hyundai Motor Group is setting up a robot parts procurement division in China, LG Group and Genesis AI unveiled an adaptive industrial robot, and LG Chem announced a KRW 15 trillion R&D plan.
This Week’s Events
Hyundai Motor Group is establishing a dedicated robot parts procurement division in Guangzhou, China, to secure cost competitiveness for the mass production of humanoid robots. By leveraging China’s growing robotics ecosystem, Hyundai is attempting to diversify its supply chain and mitigate the rising costs of global parts procurement. This initiative is designed to support the group’s broader goal of achieving a robot production system capable of 30,000 units annually by 2028. Separately, LG Group has partnered with Paris-based Genesis AI to develop ‘Eno’, a general-purpose industrial robot. Eno utilizes a fast-operating vision, language, and action (VLA) loop, and Genesis AI states it is designed to move beyond pre-defined tasks. Separately, LG Chem has announced a massive KRW 15 trillion R&D investment by 2035, aiming to pivot from a traditional material supplier to an “integrated solution company.” By allocating 70% of these resources to semiconductor, mobility, and robot materials, LG Chem is betting that the future of high-profit margins lies in co-designing performance-critical materials directly with its clients.
The semiconductor sector remains the primary theater for geopolitical and economic friction. ChangXin Memory Technologies (CXMT), China’s largest domestic DRAM manufacturer, is aggressively expanding its supply of high-density DDR5 DRAM, claiming its products are 30% cheaper than Korean alternatives. As CXMT pursues a large-scale IPO to fund further expansion, it is effectively challenging the established global memory oligopoly. This rise is occurring alongside heightened U.S. scrutiny; the U.S. government has recently questioned ASML regarding the potential export of EUV lithography equipment to China. While ASML has denied any non-compliance, the tension underscores the role of these machines in improving the productivity and performance of the latest DRAM products. Meanwhile, surging memory costs are already hitting the consumer market: Apple CEO Tim Cook has warned that surging memory and storage chip costs are becoming “unsustainable,” making price increases for upcoming products like the next iPhone unavoidable. TechInsights estimates that Apple would need to add USD 270 to the next iPhone Pro to keep its profit margin intact, a clear indicator of how AI hardware demand is cascading into the consumer electronics pricing structure.
Chinese display manufacturers China Star Optoelectronics Technology (CSOT), a subsidiary of TCL Technology, and BOE Technology Group, the world’s largest display panel maker, are rapidly advancing in the OLED monitor and laptop market. CSOT is preparing to mass-produce inkjet printing (IJP) OLED panels, while BOE has begun shipping 8.6-generation OLED panels, challenging the premium market share held by Korean firms, though some in the industry doubt Chinese yields are yet high enough to pose an immediate threat. In the defense industry, Hanwha Aerospace, South Korea’s largest defense contractor, is seeking additional orders in the European market by signing an MOU with Thales to develop compatibility between its Cheonmu guided missile system and the X-Fire launcher. This integration is designed to increase localization and secure further European defense orders, building on existing contracts in Poland, Estonia, and Norway. Meanwhile, HD Hyundai, the world’s largest shipbuilder, is exploring the establishment of a shipbuilding yard in India, a move that would leverage India’s labor force and market growth to expand the reach of the Korean shipbuilding ecosystem, aligning with India’s goal to become the world’s fifth-largest shipbuilding power by 2047.
Finally, the integration of AI into pharmaceutical R&D is gaining momentum as a way to shorten discovery timelines. SK Biopharmaceuticals, a South Korean pharmaceutical company focused on central-nervous-system drugs, has signed a multi-target R&D agreement with Insilico Medicine, a generative AI-based drug discovery firm, in a deal valued at up to USD 2.57 billion. By utilizing Insilico’s ‘Pharma.AI’ platform, SK Biopharmaceuticals aims to shorten the discovery of CNS drug candidates by nearly 50%. SK Biopharmaceuticals’ president said the significance of the agreement is that the company will serve as an “East-West bridge” connecting the Asia-based AI drug discovery ecosystem and the U.S. clinical and commercialization infrastructure it has through cenobamate.
Looking Ahead
Investors should monitor the progress of CXMT’s IPO, as its success could significantly impact global DRAM pricing and further challenge the dominance of Korean semiconductor firms. Additionally, watch for official confirmation of HD Hyundai’s shipbuilding plans in India. Finally, keep an eye on the U.S. government’s follow-up regarding ASML’s export compliance; any further restrictions or investigations could significantly affect ASML’s ability to supply EUV equipment.